15 Spine Surgeon Leaders on Device Company Boards

Laura Dyrda -   Print  |
Here are 15 spine surgeons and specialists who serve on device company advisory boards.

Frank Cammisa, MD (Hospital for Special Surgery, New York City).
Dr. Cammisa is on the Scientific Advisory Board of Alphatec Spine, Corporate Medical Advisory Board of Centinel Spine, Corporate Medical Advisory Board for Paradigm Spine and Scientific Advisory Board for Spinal Kinetics. He also serves as a consultant for NuVasive and Vertebral Technologies. Dr. Cammisa is the chief of the spine service at Hospital for Special Surgery and has a special interest in minimally invasive and motion preserving spinal techniques. During his career, he has worked with professional athletes from the New York Knicks, Giants and Jets, and he serves as a spine consultant to the National Hockey League Player Association. In addition to his clinical work, Dr. Cammisa has co-authored more than 30 chapters in medical textbooks and serves as a reviewer for many national journals. He is the founder of the National Spinal Research Foundation and member of the Spine Arthroplasty Society, North American Spine Society and Cervical Spine Research Society. Dr. Cammisa earned his medical degree at the College of Physicians and Surgeons in New York City and completed his residency at Hospital for Special Surgery. His additional training includes a spine surgery fellowship at the University of Miami.

Andrew Cappuccino, MD (Buffalo Spine Surgery, Lockport, N.Y.).
Dr. Cappuccino is the chairman of the Surgeon Advisory Board for spine device company Lanx. He is a spine surgeon with Buffalo Spine Surgery and an assistant team orthopedic surgeon with the Buffalo Bills. In addition to his clinical work, Dr. Cappuccino is a fellow of the American Academy of Orthopaedic Surgeons and member of the North American Spine Society and Spine Arthroplasty Society. His previous research projects include examining the implantation of cervical discs and the use of rhBMP-2 during posterolateral fusion. Dr. Cappuccino earned his medical degree at State University of new York at Buffalo School of Medicine and completed his fellowship at Johns Hopkins University at the Scoliosis and Spine Center in Baltimore.

Kingsley R. Chin, MD (Institute for Minimally Invasive Spine Surgery, West Palm Beach, Fla.).
Dr. Chin is the founder, CEO and President of SpineFrontier and has served on the Medical Advisory Board for Ramco Capital Corp. He is also the inventor of MANTIS and FACETFUSE spine surgery devices. Dr. Chin founded the Institute for Minimally Invasive Spine Surgery, where he serves as CEO. During his career, Dr. Chin served as the chief of spine surgery at the University of Pennsylvania in Philadelphia and has published several articles in professional journals. He is a diplomat of the National Board of Medical Examiners and American Board of Orthopaedic Surgeons. He earned his medical degree at Harvard University in Boston and completed the Harvard Combined Orthopaedic Residency with Massachusetts General Hospital in Boston. His additional training includes a fellowship in adult reconstructive surgery at Harvard and a fellowship in spine surgery at Case Western Reserve University in Cleveland.

Ryan DenHaese, MD (Buffalo Spine Surgery, Lockport, N.Y.).
Dr. DenHaese is the medical education director Lanx's new training program. He is a spine surgeon at Buffalo Spine Surgery and an attending surgeon at Sisters Hospital of Buffalo and Kenmore Mercy Hospital in New York. In addition to his clinical practice, Dr. DenHaese is a member of the American Academy of Sports Medicine, American Association of Neurological Surgeons and Congress of Neurological Surgeons. Throughout his career, Dr. DenHaese has given presentations on several topics, including minimally invasive spine surgery. He earned his medical degree at State University of New York at Buffalo School of Medicine and completed additional training at Roswell Park Cancer Institute.

Jeffrey Fischgrund, MD (William Beaumont Hospital, Royal Oak, Mich.).
Dr. Fischgrund recently joined TranS1 as a member of its board of directors. He is a surgeon at William Beaumont Hospital and professor of orthopedic surgery at the Oakland University School of Medicine. In addition to his clinical work, Dr. Fischgrund is editor-in-chief of the Journal of the American Academy of Orthopaedic Surgeons and spine fellowship director at Beaumont Hospital. He has vast experience working with spinal implant companies and regulatory agencies in the design and implementation of clinical studies to demonstrate safety and efficacy. Dr. Fischgrund earned his medical degree at George Washington University School of Medicine in Washington, D.C., and completed his residency at the University of Maryland Medical Center in Baltimore. His additional training includes a spine fellowship at William Beaumont Hospital.

Steven Garfin, MD (University of California, San Diego).
Dr. Garfin is the chairman of the Surgeon Advisory Board for SI-BONE, a spine device company focused on the iFuse Implant System for minimally invasive sacroiliac joint surgery. Dr. Garfin is the chairman of the orthopedics department at the University of California, San Diego and past president of both the North American Spine Society and Cervical Spine Research Society. He is currently president of the International Society for the Advancement of Spine Surgery. Throughout his career, Dr. Garfin has participated in the design and clinical trial assessments of several new techniques for correcting spinal disorders, deformities and injuries. He earned his medical degree at the University of Minnesota in Minneapolis and completed his residency in orthopedic surgery at UC San Diego. His additional training includes a spine fellowship at Pennsylvania Hospital in Philadelphia.

Mark C. Gillespy, MD (Orthopaedic Clinic of Daytona Beach, Fla.).
Dr. Gillespy is a clinical advisor to Ascendx Spine. He practices with Orthopaedic Clinic of Daytona Beach and is a member of several professional organizations including the North American Spine Society and American Academy of Orthopaedic Surgeons. His clinical interests include minimally invasive surgical technique and he has developed less invasive approaches for spinal fractures and fusions. Dr. Gillespy earned his medical degree at Jefferson Medical College in Philadelphia and completed his residency in orthopedics at the University of Florida in Gainesville. His additional training includes the AO Fellowship in Bern, Switzerland.

Gerard J. Girasole, MD (OSM: The Orthopaedic & Sports Medicine Center, Trumbull, Conn.).
Dr. Girasole is the chair of Bacterin's Spine/Neuro Surgeon Advisory Board. His clinical expertise includes cervical and lumbar spine surgery and he is active in minimally invasive spinal procedures. In addition to his clinical practice, Dr. Girasole is a member of the American Academy of Orthopaedic Surgeons and North American Spine Society. He participated in an FDA trial study for total disc replacement and has written chapters on spondylolisthesis. Dr. Girasole earned his medical degree at New York College of Medicine in Valhalla and completed his residency in orthopedic surgery at the Catholic Medical Center of Brooklyn & Queens. His additional training includes a spine fellowship at the Hospital for Joint Diseases in New York City.

Stephen H. Hochschuler, MD (Texas Back Institute, Plano).
Dr. Hochschuler is the chairman of the Scientific Advisory Board of Physicians for Alphatec Spine. He is a co-founder of Texas Back Institute and a founding member of the board of directors for the Spine Arthroplasty Society. During his career, Dr. Hochschuler has served as president and founding member of the board of directors for the Spine Arthroplasty Society and chairman of SpineMark. He is co-founder of Innovative Spinal Technologies and founder of the spine division at Veterans Administration in Dallas. Dr. Hochschuler also serves as a clinical instructor at the University of Texas Southwestern Medical School in Dallas. He earned his medical degree at Harvard Medical School in Boston and completed his residency in orthopedic surgery at the University of Texas Southwestern Medical School and Parkland Memorial Hospital in Dallas.

John P. Kostuik, MD (Formerly Johns Hopkins University School of Medicine).
Dr. Kostuik is the founder, past chairman and chief medical officer for spine device company K2M. Previously, Dr. Kostuik was the chief of spine surgery at Johns Hopkins University School of Medicine and served as president of both the Scoliosis Research Society and North American Spine Society. During his career, Dr. Kostuik authored several articles based on spine surgery and spent time comparing advanced spinal technologies and patient treatments. He has been a key note speaker at several spine society meetings and has trained more than 150 international spine fellows. Dr. Kostuik earned his medical degree at Queens University Faculty of Health Sciences in Canada.

Carl Lauryssen, MD (Olympia Medical Center, Beverly Hills, Calif.).
Dr. Lauryssen is on the surgeon advisory board for TransCorp Spine. He is co-director of spine research and development at Olympia Medical Center, where his research and surgical interests have included minimally invasive surgery and motion preserving techniques. During his career, he was one of the first neurosurgeons to inject stem cells into a human spinal cord during an FDA clinical trial. Previously, Dr. Lauryssen was director of advanced neurosurgical spine at Barnes-Jewish Hospital and on the faculty at Washington University School of Medicine, both in St. Louis. He is a past president of the Congress of Neurological Surgeons. Dr. Lauryssen earned his medical degree at the University of Cape Town in South Africa and completed his residency at the University of Calgary in Canada. His additional training includes a spinal neurosurgical fellowship at the University of Alabama School of Medicine in Birmingham.

Isador Lieberman, MD (Texas Back Institute, Plano).
Dr. Lieberman is on the Medical Advisory Board for Mazor Robotics, makers of the Renaissance system for robotic-assisted minimally invasive spine surgery. Dr. Lieberman is the director of scoliosis and spine tumor center at Texas Back Institute. In addition to his clinical work, Dr. Lieberman is a member of North American Spine Society, American Academy of Orthopaedic Surgeons, International Society for the Advancement of Spine Surgery and Scoliosis Research Society. Dr. Lieberman earned his medical degree at the University of Toronto, Faculty of Medicine, in Canada and completed his orthopedic surgery residency at Hospital for Sick Children in Toronto. His additional training includes a spine and trauma fellowship at The Toronto Hospital.

Harvinder S. Sandhu, MD (Hospital for Special Surgery, New York City).
Dr. Sandhu is on the Surgeon Advisory Board for Amedica, Osteotech, Providence Medical Technology, Simpirica and Spine Wave. He is a spine surgeon and assistant scientist in the research division at Hospital for Special Surgery. Previously, Dr. Sandhu served as chief of spinal surgery service at the University of California, Los Angeles Medical Center. During his career, Dr. Sandhu has published numerous peer-review articles on topics such as biologic enhancement of spine surgery and minimally invasive technique. His research has received awards from the North American Spine Society, Orthopaedic Research Society and International Society for the Study of the Lumbar Spine. He also holds several patents for the diagnosis and treatment of spinal disorders. Dr. Sandhu earned his medical degree at Northwestern University in Illinois and completed his residency at State University of New York. His additional training includes a fellowship at the University of California at Los Angeles.

Jonathan Slotkin, MD (Geisinger Health System, Danville, Conn.).
Dr. Slotkin is medical director of InVivo Therapeutics, a medical device company focused on solutions for patients with spinal cord injury. In this role, he assists the company with regulatory submissions, clinical and medical reporting and clinical trail monitoring. His expertise includes minimally invasive and complex spine surgery as well as spinal oncology. At Geisinger, Dr. Slotkin is the director of spinal surgery and director of spinal cord research. He earned his medical degree at the University of Maryland School of Medicine in Baltimore and completed his residency at Brigham and Women's Hospital. His additional training includes a fellowship at New England Baptist Hospital in Boston.

Eric J. Woodard, MD (England Baptist Hospital, Boston).
Dr. Woodard is the chief medical officer for InVivo Therapeutics. He is also the chief of neurosurgery at New England Baptist Hospital, where he established the neurosurgery fellowship in spine surgery. Previously, Dr. Woodard served as the chief of the division of spine surgery at Brigham and Women's Hospital and assistant professor in surgery at Harvard Medical School in Boston. In addition to his clinical work, he has been on the editorial board for the Journal of Spinal Disorders and SpineUniverse. Dr. Woodard is a member of several professional societies, including North American Spine Society and Congress of Neurological Surgeons. Dr. Woodard earned his medical degree at Pennsylvania State University and completed his residency in neurological surgery at Emory University in Atlanta. His additional training includes a complex spine surgery fellowship at the Medical College of Wisconsin in Milwaukee.

More Articles on Spine Surgeons:

15 Spine Surgeon Leaders for Professional Journals

15 Spine Surgeons Recognized for Research

10 Spine Surgeons at Community Hospitals


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers